forecasted

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Opportunity Number: RFA-NS-26-001CFDA Numbers: 93.853
Posted: Closed on Aug 28, 2025

Stay Updated

Get notified about new opportunities matching your interests.